Manufacturing viral gene therapy vectors: general approaches and challenges
36 min
Prof. John T. Gray Audentes Therapeutics Inc., USA
1 TalkBiography
John Gray is the Vice President of Research & Development at Audentes Therapeutics, a biotechnology company committed to the development and commercialization of novel gene therapies for people with serious, rare diseases. He received his undergraduate degree in biochemistry at the University of California, Berkeley, and Ph.D. from the University... read moreof Colorado, Boulder. He has been working on the design and manufacturing of engineered viral vectors in both academia and industry for over 20 years.
